TriangleNCT01431209 · OUTCOME
Overall Response Rate
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 24 weeks
What was measured
Number of patients achieving overall response rate
Groups in this outcome
Diffuse Large B-cell Lymphoma (DLBCL)
Patients receive ruxolitinib phosphate PO BID on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Ruxolitinib Phosphate: Given PO
Peripheral T-cell Non-Hodgkin Lymphoma (PTCL)
Patients receive ruxolitinib phosphate PO BID on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Ruxolitinib Phosphate: Given PO
| Group | Source count |
|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | 47 |
| Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) | 13 |
Reported measurements
Source class 1
Complete Response
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | 1 | Not reported | Not reported | Not reported | Not reported |
| Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) | 1 | Not reported | Not reported | Not reported | Not reported |
Partial Response
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | 3 | Not reported | Not reported | Not reported | Not reported |
| Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) | 1 | Not reported | Not reported | Not reported | Not reported |
Stable disease
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | 5 | Not reported | Not reported | Not reported | Not reported |
| Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) | 3 | Not reported | Not reported | Not reported | Not reported |
Progressive disease
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | 34 | Not reported | Not reported | Not reported | Not reported |
| Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) | 7 | Not reported | Not reported | Not reported | Not reported |
Not assessed
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | 4 | Not reported | Not reported | Not reported | Not reported |
| Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) | 1 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 1
- title
- Complete Response
- measurements
- group Id
- OG000
- value
- 3
- group Id
- OG001
- value
- 1
- title
- Partial Response
- measurements
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 3
- title
- Stable disease
- measurements
- group Id
- OG000
- value
- 34
- group Id
- OG001
- value
- 7
- title
- Progressive disease
- measurements
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 1
- title
- Not assessed
- denoms
- counts
- group Id
- OG000
- value
- 47
- group Id
- OG001
- value
- 13
- units
- Participants
- description
- Number of patients achieving overall response rate
- groups
- description
- Patients receive ruxolitinib phosphate PO BID on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Ruxolitinib Phosphate: Given PO
- id
- OG000
- title
- Diffuse Large B-cell Lymphoma (DLBCL)
- description
- Patients receive ruxolitinib phosphate PO BID on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Ruxolitinib Phosphate: Given PO
- id
- OG001
- title
- Peripheral T-cell Non-Hodgkin Lymphoma (PTCL)
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- 24 weeks
- title
- Overall Response Rate
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice